VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
453
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
91
Interactions with Platform & by Email
PARTICIPANTS
18
Unique # Participated
VALIDATIONS
8
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JUL 2020
TABLES
111
PAGES
188
EDITION
9
PRICE
USD $4950
The U.S. Economy is Reinventing Itself to Weather Economic Storms.
Here's An Analytical Window into the Changing Opportunities.
Amid the COVID-19 crisis, the global market for Therapeutic Plasma Exchange estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.9% over the analysis period 2020-2027. Neurological Disorders, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$622 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Renal Disorders segment is readjusted to a revised 5.2% CAGR for the next 7-year period.
The Therapeutic Plasma Exchange market in the U.S. is estimated at US$347.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$308.9 Million by the year 2027 trailing a CAGR of 5.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.
In the global Hematology Disorders segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$180.5 Million in the year 2020 will reach a projected size of US$274 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$201.9 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 188-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International, Inc.; Fenwal, Inc.; Fresenius SE & Co. KGaA; Haemonetics Corporation; HemaCare Corporation; Kawasumi Laboratories, Inc.; Terumo BCT, Inc.
» Disease Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders, Other Disease Indications) » End-Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Therapeutic Plasma Exchange Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Therapeutic Plasma Exchange Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Therapeutic Plasma Exchange Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017 |
| Therapeutic Plasma Exchange Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Hospitals (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2018 through 2025 |
| Hospitals (End-Use) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2009 to 2017 |
| Hospitals (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| Specialty Clinics (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025 |
| Specialty Clinics (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Specialty Clinics (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Ambulatory Surgical Centers (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025 |
| Ambulatory Surgical Centers (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017 |
| Ambulatory Surgical Centers (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 |
| Neurological Disorders (Disease Indication) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Neurological Disorders (Disease Indication) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Neurological Disorders (Disease Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Renal Disorders (Disease Indication) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 |
| Renal Disorders (Disease Indication) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 |
| Renal Disorders (Disease Indication) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Hematology Disorders (Disease Indication) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025 |
| Hematology Disorders (Disease Indication) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017 |
| Hematology Disorders (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Metabolic Disorders (Disease Indication) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025 |
| Metabolic Disorders (Disease Indication) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017 |
| Metabolic Disorders (Disease Indication) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Other Disease Indications (Disease Indication) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Other Disease Indications (Disease Indication) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Other Disease Indications (Disease Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Therapeutic Plasma Exchange Market Share (in %) by Company: 2019 & 2025 |
| United States Therapeutic Plasma Exchange Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025 |
| Therapeutic Plasma Exchange Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2009-2017 |
| Therapeutic Plasma Exchange Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025 |
| United States Therapeutic Plasma Exchange Market Estimates and Projections in US$ Thousand by Disease Indication: 2018 to 2025 |
| Therapeutic Plasma Exchange Market in the United States by Disease Indication: A Historic Review in US$ Thousand for 2009-2017 |
| United States Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Therapeutic Plasma Exchange Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025 |
| Therapeutic Plasma Exchange Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 |
| Canadian Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Canadian Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018 to 2025 |
| Canadian Therapeutic Plasma Exchange Historic Market Review by Disease Indication in US$ Thousand: 2009-2017 |
| Therapeutic Plasma Exchange Market in Canada: Percentage Share Breakdown of Sales by Disease Indication for 2009, 2019, and 2025 |
| JAPAN |
| Japanese Demand Estimates and Forecasts for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025 |
| Japanese Therapeutic Plasma Exchange Market in US$ Thousand by End-Use: 2009-2017 |
| Therapeutic Plasma Exchange Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025 |
| Japanese Market for Therapeutic Plasma Exchange: Annual Sales Estimates and Projections in US$ Thousand by Disease Indication for the Period 2018-2025 |
| Therapeutic Plasma Exchange Market in Japan: Historic Sales Analysis in US$ Thousand by Disease Indication for the Period 2009-2017 |
| Japanese Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Demand for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025 |
| Therapeutic Plasma Exchange Market Review in China in US$ Thousand by End-Use: 2009-2017 |
| Chinese Therapeutic Plasma Exchange Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| Chinese Therapeutic Plasma Exchange Market Growth Prospects in US$ Thousand by Disease Indication for the Period 2018-2025 |
| Therapeutic Plasma Exchange Historic Market Analysis in China in US$ Thousand by Disease Indication: 2009-2017 |
| Chinese Therapeutic Plasma Exchange Market by Disease Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| EUROPE |
| Market Facts & Figures |
| European Therapeutic Plasma Exchange Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Therapeutic Plasma Exchange Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
| Therapeutic Plasma Exchange Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017 |
| European Therapeutic Plasma Exchange Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Therapeutic Plasma Exchange Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 |
| Therapeutic Plasma Exchange Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 |
| European Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| European Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018-2025 |
| Therapeutic Plasma Exchange Market in Europe in US$ Thousand by Disease Indication: A Historic Review for the Period 2009-2017 |
| European Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025 |
| FRANCE |
| Therapeutic Plasma Exchange Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2018-2025 |
| French Therapeutic Plasma Exchange Historic Market Review in US$ Thousand by End-Use: 2009-2017 |
| French Therapeutic Plasma Exchange Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| Therapeutic Plasma Exchange Market in France by Disease Indication: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| French Therapeutic Plasma Exchange Historic Market Scenario in US$ Thousand by Disease Indication: 2009-2017 |
| French Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025 |
| GERMANY |
| Therapeutic Plasma Exchange Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025 |
| German Therapeutic Plasma Exchange Market in Retrospect in US$ Thousand by End-Use: 2009-2017 |
| Therapeutic Plasma Exchange Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025 |
| Therapeutic Plasma Exchange Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease Indication for the Period 2018-2025 |
| German Therapeutic Plasma Exchange Historic Market Analysis in US$ Thousand by Disease Indication: 2009-2017 |
| German Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Demand for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025 |
| Therapeutic Plasma Exchange Market Review in Italy in US$ Thousand by End-Use: 2009-2017 |
| Italian Therapeutic Plasma Exchange Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| Italian Therapeutic Plasma Exchange Market Growth Prospects in US$ Thousand by Disease Indication for the Period 2018-2025 |
| Therapeutic Plasma Exchange Historic Market Analysis in Italy in US$ Thousand by Disease Indication: 2009-2017 |
| Italian Therapeutic Plasma Exchange Market by Disease Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| UNITED KINGDOM |
| United Kingdom Demand Estimates and Forecasts for Therapeutic Plasma Exchange in US$ Thousand by End-Use: 2018 to 2025 |
| United Kingdom Therapeutic Plasma Exchange Market in US$ Thousand by End-Use: 2009-2017 |
| Therapeutic Plasma Exchange Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025 |
| United Kingdom Market for Therapeutic Plasma Exchange: Annual Sales Estimates and Projections in US$ Thousand by Disease Indication for the Period 2018-2025 |
| Therapeutic Plasma Exchange Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Disease Indication for the Period 2009-2017 |
| United Kingdom Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Therapeutic Plasma Exchange Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 |
| Therapeutic Plasma Exchange Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 |
| Rest of Europe Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Rest of Europe Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018-2025 |
| Therapeutic Plasma Exchange Market in Rest of Europe in US$ Thousand by Disease Indication: A Historic Review for the Period 2009-2017 |
| Rest of Europe Therapeutic Plasma Exchange Market Share Breakdown by Disease Indication: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Therapeutic Plasma Exchange Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025 |
| Asia-Pacific Therapeutic Plasma Exchange Historic Market Review in US$ Thousand by End-Use: 2009-2017 |
| Asia-Pacific Therapeutic Plasma Exchange Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| Therapeutic Plasma Exchange Market in Asia-Pacific by Disease Indication: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Asia-Pacific Therapeutic Plasma Exchange Historic Market Scenario in US$ Thousand by Disease Indication: 2009-2017 |
| Asia-Pacific Therapeutic Plasma Exchange Market Share Analysis by Disease Indication: 2009 VS 2019 VS 2025 |
| REST OF WORLD |
| Rest of World Therapeutic Plasma Exchange Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025 |
| Therapeutic Plasma Exchange Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 |
| Rest of World Therapeutic Plasma Exchange Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| Rest of World Therapeutic Plasma Exchange Market Estimates and Forecasts in US$ Thousand by Disease Indication: 2018 to 2025 |
| Rest of World Therapeutic Plasma Exchange Historic Market Review by Disease Indication in US$ Thousand: 2009-2017 |
| Therapeutic Plasma Exchange Market in Rest of World: Percentage Share Breakdown of Sales by Disease Indication for 2009, 2019, and 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 47 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com